Metabolic & Incretin Research
Single, dual, and triple incretin receptor agonists (GLP-1R, GIPR, GCGR), amylin analogues, and AMPK/NNMT metabolic reference compounds.
Scientific Overview: Metabolic & Incretin Research
Our Metabolic & Incretin Research catalog spans next-generation acylated polypeptide agonists targeting GLP-1R (Semaglutide), dual GLP-1R/GIPR (Tirzepatide), dual GLP-1R/GCGR (Survodutide, Mazdutide), triple GLP-1R/GIPR/GCGR (Retatrutide), and calcitonin/amylin receptors (Cagrilintide), alongside non-peptide metabolic probes such as 5-Amino-1MQ, AICAR, and SLU-PP-332.
Acylated incretins (31–39 amino acids with C18/C20 fatty-diacid albumin linkers) require strict thermal control and high-resolution ESI-MS verification to confirm full side-chain acylation without truncation or deamidation byproducts.
Primary Research Mechanisms
- GLP-1, GIP, and Glucagon GPCR agonism
- Fatty-diacid albumin binding & extended half-life kinetics
- AMPK, ERRα/β/γ, and NNMT cellular energy pathways
- Lipolytic hGH fragment 176–191 models
Related Metabolic & Incretin Research Monographs
SLU-PP-332: Synthetic Pan-ERR Agonist Chemistry, DMSO Solubility & Mitochondrial Biogenesis
Analytical profile of small-molecule pan-ERR agonist SLU-PP-332 (CAS 303760-60-3): nuclear receptor EC50 selectivity, mitochondrial respiration models, and DMSO stock preparation.
Cagrilintide vs Retatrutide: Amylin/Calcitonin Receptors vs Triple Incretin Agonism
Biochemical comparison of long-acting amylin analogue Cagrilintide (AM833) against triple incretin agonist Retatrutide and dual-pathway Cagrilintide + Semaglutide combinations.
Survodutide vs Mazdutide vs Retatrutide: Dual GLP-1/Glucagon and Triple Agonist Biochemistry
Comparative receptor pharmacology of Survodutide (BI 456906), Mazdutide (IBI362), and Retatrutide (LY3437943): GLP-1R/GCGR/GIPR potency ratios and stability.
Metabolic & Incretin Research — Technical FAQ
Why do acylated incretin peptides require cold-chain logistics?
Long-chain acylated GLP-1/GIP/glucagon analogues contain fatty-diacid side chains and labile residues susceptible to deamidation and aggregation at elevated temperatures. SwissLab dispatches all metabolic vials in insulated thermal packaging.
How should hydrophobic metabolic compounds like AOD-9604 or SLU-PP-332 be solubilized?
While standard incretin salts dissolve in sterile water or buffered saline (pH 7.4), hydrophobic compounds such as AOD-9604 may require initial dissolution in 0.6% sterile acetic acid, and small-molecule ERR agonists like SLU-PP-332 require sterile DMSO stock preparation.
Do small-molecule metabolic probes like 5-Amino-1MQ use peptide Net Peptide Content math?
No. 5-Amino-1MQ is a quaternary quinolinium iodide salt (~44.3% iodide mass by weight), so molarity calculations should correct for the iodide counterion mass rather than polypeptide TFA/acetate NPC factors.